25I-NBF
Encyclopedic
Encyclopedic
Typical encyclopedia coverage. Cross-reference for important decisions.
- 4 corroborating sources
- 3 ROAs with full dose ladders
- duration data present
- 28 combo interactions documented
- classified Tentative
- classified Research-chemical
- 4 corroborating sources
- 3 ROAs with full dose ladders
- duration data present
- 28 combo interactions documented
- classified Tentative
- classified Research-chemical
Aliases: 2c-i-nbf, Nbf-2c-i, Cimbi-21
Summary
25I-NBF (Cimbi-21) is a psychedelic phenethylamine and research chemical. It acts primarily through potent partial agonism at 5-HT2A and 5-HT2C receptors with bias toward ฮฒ-arrestin 2 signaling, while peripheral ฮฑ-adrenergic activity contributes to vasoconstriction and cardiovascular strain. It is approximately 6-8 times less potent than 25I-NBOMe but shares a similar qualitative effect profile and comparable safety concerns. Oral bioavailability is low, so sublingual, buccal, or insufflated administration is typically used.
Dose Information
Dose basis. Sublingual: Ranges are primarily from user reports and harm-reduction compendia; individual response varies widely. Volumetric dosing is strongly recommended due to mg-level potency and dosing error risk. Insufflated: Intranasal use increases adverse vasoconstrictive and cardiovascular effects; liquid (volumetric) nasal dosing is advised over dry powder to reduce hot-spots and local tissue irritation. (Dose figures and this note are from Drugs.Wiki.)
| ROA | Light | Common | Strong | Heavy |
|---|---|---|---|---|
| Sublingual | 2-4mg | 4-8mg | 8-12mg | 12mg+ |
| Insufflated | 1-2mg | 2-5mg | 5-8mg | 8mg+ |
| Oral | 6-10mg | 10-16mg | 16-22mg | 22mg+ |
Sources
Sublingual
Dose ladder — Drugs.WikiInsufflated
Dose ladder — Drugs.WikiOral
Dose ladder — Drugs.WikiOnset, Duration & After-effects
| ROA | Onset | Comeup | Peak | Offset | Total |
|---|---|---|---|---|---|
| Sublingual | 10-30 min | 30-60 min | 2-4 hrs | 2-4 hrs | 4.67-9.5 hrs |
| Insufflated | 5-15 min | 20-45 min | 2-4 hrs | 2-4 hrs | 4.41-9 hrs |
| Oral | 30-60 min | 45-90 min | 2-4 hrs | 2-4 hrs | 5.25-10.5 hrs |
Effect Profile
Scores (0–10) curated from multiple sources:
- Effect keyword matching from PsychonautWiki catalog
- Weighted by importance: core (×3), major (×2), minor (×1)
Strong visuals with moderate headspace and body load, mild auditory effects
Moderate euphoria with strong anxiety/jitters, low stimulation and focus
Tolerance
Tolerance Decay
Rapid tolerance build similar to NBOMe/LSD is reported anecdotally; noticeable tolerance persists several days and may take 1โ2 weeks to normalize.
Cross-Tolerances
Effects
Effect glossary — · full glossary
Combinations
Cross-Check 25I-NBF with another substanceHelpful Links
Add to PsychonautWiki Journal
The PsychonautWiki Journal logging app doesn't include every substance. To track 25I-NBF there, start adding an ingestion, search for the name, and choose to add it as a custom substance. Paste these values:
25I-NBF Source: SubstanceSearch (substancesearch.com) Sublingual dose (mg): threshold 1-2 ยท light 2-4 ยท common 4-8 ยท strong 8-12 ยท heavy 12+ Insufflated dose (mg): threshold 0.5 ยท light 1-2 ยท common 2-5 ยท strong 5-8 ยท heavy 8+ Oral dose (mg): threshold 4 ยท light 6-10 ยท common 10-16 ยท strong 16-22 ยท heavy 22+ Sublingual duration: onset 10-30m ยท come-up 0.5-1h ยท peak 2-4h ยท offset 2-4h ยท total 4.67-9.5h ยท after-effects 2-8h Insufflated duration: onset 5-15m ยท come-up 20-45m ยท peak 2-4h ยท offset 2-4h ยท total 4.41-9h ยท after-effects 2-8h Oral duration: onset 0.5-1h ยท come-up 0.75-1.5h ยท peak 2-4h ยท offset 2-4h ยท total 5.25-10.5h ยท after-effects 2-8h Note: ranges are harm-reduction guidance, not a prescription. Start low, go slow, and test your substances.
Tip: for quicker logging you can also add a Custom Unit in the app, e.g. common dose ~ 6 mg (Sublingual).
The app keeps custom substances simple, so the full dose ranges live in the description text above. Ranges are harm-reduction guidance, not a prescription.
Report an issue or suggest an edit
Spotted incorrect or dangerous information, have a correction, a new study, or a useful addition for 25I-NBF? Let us know. Reports are reviewed by moderators — this is not posted publicly.